hims & hers glp-1 set for Super Bowl ad debut highlighting weight loss drugs Despite the Stigma, Hims &

Weight Loss Results: What the Data Shows When it comes to shedding pounds, injectable GLP-1s deliver superior results based on extensive clinical trials: Injectable semaglutide (Wegovy ) : 15-17% average body weight loss Injectable tirzepatide (Mounjaro /Zepboun d) : Up to 22.5% average body weight loss FDA-approved oral semaglutide: 13.6-16.6% average body weight loss Compounded ODT formulations : No published clinical trial data available A real-world comparison study found that patients on injectable semaglutide lost 1.62kg more than those on FDA-approved oral semaglutide over 26 weeks, which was not significant

Syringes or pen needles

Signal Transduct Target Ther 9(1):234

Sterile environments, precision equipment, and the controlled conditions required for peptide synthesis mean that the physical infrastructure itself becomes a scalability challenge

Q: Are they the same as insulin

While evidence clearly supports bariatric surgery as a safe and effective treatment for obesity, emotional hesitation often overshadows medical facts